Skip to content

Author

S. Waymack

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cardiac safety of L-Annamycin: a pooled analysis of five clinical trials

Background Anthracyclines are highly effective chemotherapeutic agents but are limited by cumulative, dose-dependent cardiotoxicity, leading to strict lifetime exposure thresholds. L-Annamycin is a next-generation liposomal anthracycline designed to preserve antitumor efficacy while reducing cardiotoxicity. Methods We...

Z. Zalaquett, S. Waymack, P. Collier · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.